Agilent Technologies Inc (A)

Return on equity (ROE)

Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020 Apr 30, 2020 Jan 31, 2020
Net income (ttm) US$ in thousands 1,289,000 1,413,000 1,242,000 1,236,000 1,240,000 1,133,000 1,351,000 1,323,000 1,254,000 1,328,000 1,263,000 1,205,000 1,210,000 990,000 925,000 810,000 719,000 691,000 683,000 764,000
Total stockholders’ equity US$ in thousands 5,898,000 5,903,000 6,214,000 6,188,000 5,845,000 5,558,000 5,781,000 5,609,000 5,305,000 5,091,000 5,122,000 5,154,000 5,389,000 4,946,000 4,810,000 4,804,000 4,873,000 4,981,000 4,768,000 4,848,000
ROE 21.85% 23.94% 19.99% 19.97% 21.21% 20.39% 23.37% 23.59% 23.64% 26.09% 24.66% 23.38% 22.45% 20.02% 19.23% 16.86% 14.75% 13.87% 14.32% 15.76%

October 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $1,289,000K ÷ $5,898,000K
= 21.85%

Agilent Technologies Inc has shown a fluctuating trend in return on equity (ROE) over the past few years. The ROE percentages have ranged from a low of 13.87% in January 2020 to a high of 26.09% in July 2022. Overall, the ROE has generally been above 15% over the given period, indicating that the company has been generating favorable returns for its shareholders.

The ROE for the most recent quarter, ending October 31, 2024, was 21.85%, showing a slight decrease from the previous quarter's 23.94%. Despite this decrease, the current ROE is still within a reasonable range compared to historical figures.

It is important to note that while ROE is a key indicator of a company's profitability and efficiency in utilizing shareholder equity, it should be analyzed in conjunction with other financial metrics to gain a comprehensive understanding of Agilent Technologies Inc's financial performance.


Peer comparison

Oct 31, 2024

Company name
Symbol
ROE
Agilent Technologies Inc
A
21.85%
Cohu Inc
COHU
2.96%
Itron Inc
ITRI
7.39%
Teradyne Inc
TER
17.77%